Leonetti A - Search Results

1

Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.

Leonetti A, Peroni M, Agnetti V, Pratticò F, Manini M, Acunzo A, Marverti F, Sulas S, Rapacchi E, Mazzaschi G, Perrone F, Bordi P, Buti S, Tiseo M. Leonetti A, et al. BMJ Support Palliat Care. 2023 Sep 4:spcare-2023-004558. doi: 10.1136/spcare-2023-004558. Online ahead of print. BMJ Support Palliat Care. 2023. PMID: 37666650

2

Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review.

Leonetti A, Bersanelli M, Castagneto B, Masini C, Di Meglio G, Pellegrino B, Buti S. Leonetti A, et al. Clin Genitourin Cancer. 2016 Aug;14(4):277-83. doi: 10.1016/j.clgc.2016.01.010. Epub 2016 Jan 28. Clin Genitourin Cancer. 2016. PMID: 26899142 Review.

3

Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.

Pellegrino B, Sikokis A, Bersanelli M, Leonetti A, Leonardi F, Di Meglio G, Buti S. Pellegrino B, et al. Among authors: leonetti a. Gynecol Obstet Invest. 2016;81(5):385-93. doi: 10.1159/000446954. Epub 2016 Jun 17. Gynecol Obstet Invest. 2016. PMID: 27309542 Review.

4

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy.

Buti S, Leonetti A, Dallatomasina A, Bersanelli M. Buti S, et al. Among authors: leonetti a. Core Evid. 2016 Sep 1;11:23-36. doi: 10.2147/CE.S98687. eCollection 2016. Core Evid. 2016. PMID: 27621699 Free PMC article. Review.

5

"Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?

Bersanelli M, Leonetti A, Buti S, Michiara M. Bersanelli M, et al. Among authors: leonetti a. Lancet Oncol. 2017 Jun;18(6):e298. doi: 10.1016/S1470-2045(17)30349-2. Lancet Oncol. 2017. PMID: 28593853 No abstract available.

6

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma.

Leonetti A, Leonardi F, Bersanelli M, Buti S. Leonetti A, et al. Ther Clin Risk Manag. 2017 Jun 30;13:799-806. doi: 10.2147/TCRM.S126910. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 28721060 Free PMC article. Review.

7

The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade.

Bersanelli M, Leonetti A, Buti S. Bersanelli M, et al. Among authors: leonetti a. Immunotherapy. 2017 Nov;9(14):1127-1131. doi: 10.2217/imt-2017-0127. Immunotherapy. 2017. PMID: 29067883 Free article. No abstract available.

8

Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC.

Minari R, Bordi P, La Monica S, Squadrilli A, Leonetti A, Bottarelli L, Azzoni C, Lagrasta CAM, Gnetti L, Campanini N, Petronini PG, Alfieri R, Tiseo M. Minari R, et al. Among authors: leonetti a. J Thorac Oncol. 2018 Jun;13(6):e89-e91. doi: 10.1016/j.jtho.2018.03.013. Epub 2018 Mar 27. J Thorac Oncol. 2018. PMID: 29596911 Free article. No abstract available.

9

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall.

Leonetti A, Facchinetti F, Rossi G, Minari R, Conti A, Friboulet L, Tiseo M, Planchard D. Leonetti A, et al. Cancer Treat Rev. 2018 May;66:82-94. doi: 10.1016/j.ctrv.2018.04.006. Epub 2018 Apr 24. Cancer Treat Rev. 2018. PMID: 29729495 Review.

10

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present).

Leonetti A, Zielli T, Buti S. Leonetti A, et al. Future Oncol. 2018 Sep;14(22):2223-2224. doi: 10.2217/fon-2018-0304. Epub 2018 Aug 1. Future Oncol. 2018. PMID: 30064274 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page